MedTrace Logo

Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100

NCT03450070 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2019-05-15

Study results available
· View outcomes & findings →

Summary

Patch Testing for device cream on human subjects

Conditions

  • Allergic Sensitization

Interventions

DEVICE

Light Therapy Mask Cream

test panel

Sponsors & Collaborators

  • Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-15
Primary Completion
2017-12-22
Completion
2017-12-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03450070 on ClinicalTrials.gov